##  [Novartis interim results from global, pivotal CTL019 trial show durable complete responses in adults with r/r DLBCL](/us-en/news/media-releases/novartis-interim-results-from-global-pivotal-ctl019-trial-show-durable-complete-responses-adults-rr-dlbcl-0 "Novartis interim results from global, pivotal CTL019 trial show durable complete responses in adults with r/r DLBCL") 

  Jun 07, 2017